Deal Announcements

Janus Biotherapeutics Lands Partial VC Funding

Monday, August 22, 2011 5:31:00 AM PDT | VentureDeal Staff

Wellesley, Massachusetts  --  Stealth biotechnology company Janus Biotherapeutics (no website) has received $1.1 million in new venture capital investment, according to an SEC regulatory filing.

Janus says that it is focused on "progressing a series of small molecule leads for the treatment of autoimmune diseases."

Investors in the financing were not disclosed. The company is still seeking an additional $1.9 million in financing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1